[NS398 induced apoptosis in pancreatic carcinoma cell strain BxPC-3 through a COX-2-in dependent pathway]
Dong-sheng Huang1, Xiao Xu, Shu-sen Zheng
1Department of Hepatobiliary Pancreatic Surgery, the First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou 310003, China. dshuang@mail.hz.zj.cn
Objective:
To investigate the effects of the selective cyclooxygenase-2 (COX-2) inhibitor NS398 on the growth of human pancreatic tumor BxPC-3 cell strain and its possible mechanisms.
Methods:
The effect of NS398 on cell growth was assessed by 3- (4,5-dimethylthiazol-2-yl) -2, 5-diphenyl thiazolyl blue (MTT) assay. Apoptosis was determined by fluorescence-activated cell scanning (FACS) analysis and assessment of the floating cell/attached cell ratio. Caspase-3 activation was evaluated by Active Caspase-3 Apoptosis Kit with flow cytometry. Reverse transcriptase-polymerase chain reaction analysis (RT-PCR) and Western blot were used to demonstrate expression levels of COX-1, COX-2 mRNA, and protein, as well as Caspase-3 protein in pancreatic tumor BxPC-3 cell strain.
Results:
Selective COX-2 inhibitor NS398 significantly decreased cell viability and induced apoptosis in pancreatic tumor BxPC-3 cell strain. The protein expression of Caspase-3 was induced by high-concentration NS398. Caspase-3 activity was strongly activated by NS398.
Conclusions:
Selective COX-2 inhibitor NS398 has antiproliferative and proapoptotic potential in pancreatic tumor BxPC-3 cells. Such effect is independent of COX-2, but correlates with Caspase-3 activation.
Insights
The selective cyclooxygenase-2 (COX-2) inhibitor NS398 demonstrated antiproliferative and proapoptotic effects on human pancreatic cancer cells. This action was linked to Caspase-3 activation, not COX-2 inhibition.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Context:
- Pancreatic cancer remains a significant health challenge with limited effective treatments.
- Cyclooxygenase-2 (COX-2) is implicated in tumor growth and inflammation.
- Targeting specific molecular pathways is crucial for developing novel cancer therapies.
Purpose:
- To investigate the impact of the selective COX-2 inhibitor NS398 on human pancreatic tumor BxPC-3 cell line growth.
- To elucidate the underlying mechanisms of NS398's action, including its effect on apoptosis and key protein expressions.
Summary:
- NS398 significantly reduced BxPC-3 cell viability and induced apoptosis.
- High concentrations of NS398 led to increased Caspase-3 protein expression and activation.
- The observed antiproliferative and proapoptotic effects were independent of COX-2 but correlated with Caspase-3 activation.
Impact:
- This study reveals a novel therapeutic potential for NS398 in pancreatic cancer treatment.
- The findings highlight the critical role of Caspase-3 activation in mediating NS398's anti-cancer effects.
- Understanding these mechanisms could pave the way for developing more targeted pancreatic cancer therapies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis

